REQUEST A DEMO
Total
USD $0.00
Search more companies

UAB Rx Pharma (Lithuania)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers | Other Miscellaneous Nondurable Goods Merchant Wholesalers
Full name: UAB Rx Pharma Profile Updated: January 01, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Russian Download a sample report

UAB Rx Pharma is an enterprise in Lithuania, with the main office in Vilnius. It operates in the Drugs and Druggists' Sundries Merchant Wholesalers industry. It was first established on November 17, 2008. There are currently 8 (2025) people employed by UAB Rx Pharma. The company’s latest financial report indicates a net sales revenue increase of 5.64% in 2024. The enterprise’s net profit margin decreased by 0.16% in 2024.

Headquarters
Ukmerges g. 369A
Vilnius; Vilnius county; Postal Code: LT-12142

Contact Details: Purchase the UAB Rx Pharma report to view the information.

Basic Information
Total Employees:
Purchase the UAB Rx Pharma report to view the information.
Registered Capital:
Purchase the UAB Rx Pharma report to view the information.
Financial Auditors:
Purchase the UAB Rx Pharma report to view the information.
Incorporation Date:
November 17, 2008
Key Executives
Purchase this report to view the information.
Director
Company Performance
Financial values in the chart are available after UAB Rx Pharma report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency EUR. Absolute financial data is included in the purchased report.
Net sales revenue
5.64%
Total operating revenue
5.64%
Net Profit (Loss) for the Period
-2.15%
Total Equity
-12.85%
Net Profit Margin
-0.16%
Return on Equity (ROE)
1.64%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?